Back to the main directory
EarningsReview / Equity
- Elisa - Sell/EUR 44: Getting a piece of COVID-19, recovery uncertain by Nordea
- Santander CIB: ASML: Confident for 2020; Starting to Look at 2021 by Santander
- DIA: 2Q’20 TRADING UPDATE (ANÃLISIS BANCO SABADELL) by Sabadell
- Santander CIB: Verallia: 2Q20E A Test to the Cost Base Flexibility by Santander
- Asos Plc (ASC LN) by HSBC
- Aker Solutions - Improving operations by Danske Bank Equity Research
- Getinge - Profit growth set to accelerate further in Q3 by Danske Bank Equity Research
- A testing quarter by BNP Paribas Exane
- Swedish Orphan Biovitrum - Taking some short-term bruises by Danske Bank Equity Research
- Santander CIB: Alstom: 1Q20/21: Encouraging Message on 2H20/21 by Santander
- XXL - Balance sheet fixed but more structural issues ahead by Danske Bank Equity Research
- Husqvarna - All set for a strong ending to the year by Danske Bank Equity Research
- Feedback from Expert Event with UnSub by BNP Paribas Exane
- Itaú BBA on Axtel: Better-Than-Expected 2Q20 Results by Itau
- Atlas Copco - Shows its qualities but limited revisions to estimates by Danske Bank Equity Research
- Sandvik - Strong SMRT supports revaluation of the shares by Danske Bank Equity Research
- XXL (Buy, TP: NOK18.00) - Strong report as pre-warned by DnB Markets
- Konecranes (Buy, TP: EUR25.00) - Strong Q2 earnings pre-released by DnB Markets
- Elisa (Sell, TP: EUR45.00) - Pandemic slowing growth by DnB Markets
- Sparebanken Øst (Hold, TP: NOK50.00) - NII facing headwinds by DnB Markets
- Bonava (Buy, TP: SEK80.00) - KPIs remain strong by DnB Markets
- Husqvarna (Buy, TP: SEK95.00) - Set for professional products boost by DnB Markets
- Dometic (Buy, TP: SEK102.00) - Markets set to improve by DnB Markets
- Norske Skog (Hold, TP: NOK32.00) - Hit hard by Covid-19 by DnB Markets
- Borregaard (Hold, TP: NOK110.00) - Margin tailwind by DnB Markets
- Investment Daily 16/07/2020 by BNP Paribas Exane
- DIA: AVANCE VENTAS 2T’20 (ANÃLISIS BANCO SABADELL) by Sabadell
- Santander CIB: Logista: 3Q20E: Enduring the Lockdown Well by Santander
- Mycronic - Early delivery of PG machine created strong beat by Danske Bank Equity Research
- Industry on track to recovery by BNP Paribas Exane
- HiQ International - Excellent handling of the COVID-19 pandemic by Danske Bank Equity Research
- Encouraging on sales but gross margin to remain weak by BNP Paribas Exane
- Balder - Buy before investment activity picks up in H2 by Danske Bank Equity Research
- Flagship funds on a roll by BNP Paribas Exane
- Not all recoveries are the same by BNP Paribas Exane
- Revising estimates post ad hoc H1 release by BNP Paribas Exane
- Dometic - Demand restored, internal improvements to come by Danske Bank Equity Research
- Reflecting positive recent dynamics / H1 20 preview by BNP Paribas Exane
- Sweco - Tailwinds subsiding by Danske Bank Equity Research
- Adevinta - In recovery mode by Danske Bank Equity Research
- Adevinta (Sell, TP: NOK75.00) - Strong report by DnB Markets
- Sats (Hold, TP: NOK19.00) - Q2 better than feared by DnB Markets
- Castellum (Buy, TP: SEK203.00) - Earnings beat and positive outlook by DnB Markets
- Atea (Sell, TP: NOK90.00) - Near-term relief, but visibility low by DnB Markets
- Nokian Tyres (Buy, TP: EUR24.00) - Q2e upside but small 2020e impact by DnB Markets
- FLSmidth (Hold, TP: DKK200.00) - Dire Q2e, all eyes on H2 by DnB Markets
- Balder (Sell, TP: SEK350.00) - Limited investment activity in Q2 by DnB Markets
- Genmab (Hold, TP: DKK2400.00) - US Darzalex shows recovery by DnB Markets
- Adevinta (Sell, TP: NOK85.00) - France recovers by DnB Markets
- Pareto Bank (Buy, TP: NOK45.00) - Indicating resilience by DnB Markets